Over the last seven years, responsible pharmaceutical companies and their investors have worked to protect their products from being sold to prisons for misuse in capital punishment.
The importance of controlling the supply chain to prevent misuse of medicines in executions has been recognised by corporate responsibility bodies including the OECD Guidelines for Multinational Enterprises and the United Nations Global Compact.
Effective distribution control systems are in line with responsible business practice and can protect healthcare companies from the legal, financial and reputational risks associated with providing drugs for executions.
To view a complete list of all 58 companies that have been impacted in some way by the efforts of state officials to obtain execution drug supplies, click here.
For more information, please contact us.